Advertisement
U.S. markets closed

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - Nasdaq Real Time Price. Currency in USD
42.10+0.03 (+0.07%)
At close: 04:00PM EST
42.10 -0.04 (-0.09%)
After hours: 04:02PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close42.07
Open42.00
Bid41.95 x 1800
Ask42.19 x 2900
Day's Range42.02 - 42.22
52 Week Range22.89 - 45.76
Volume57,343
Avg. Volume55,070
Market Cap1.582B
Beta (5Y Monthly)0.63
PE Ratio (TTM)34.51
EPS (TTM)1.22
Earnings DateMay 21, 2024 - May 27, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 10, 2018
1y Target Est43.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-28% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TARO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Taro Pharmaceutical Industries
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    19 hours agoMorningstar
View more